Patent · US Active

Selective inhibitors of human corticosteroid synthases

US9271963B2 · kind B2 · utility

6Cited by

10References

25Claims

0Family size

Assignee

UNIVERSITAT DES SAARLANDES · DE

Inventors

Rolf Hartmann · Saarburg, DE
Marieke Voets · Herent, BE
Ursula Müller-Vieira · Saarburg, DE

Key dates

Filing date	Mar 2, 2006
Grant date	Mar 1, 2016
Priority date	—
Expiry date	Apr 20, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D263/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds for selectively inhibiting human corticosteroid synthases CYP1 1 B1 and CYP1 1 B2, and to the production and use thereof for treating hypercortisolism, diabetes mellitus, hyperaldosteronism, cardiac insufficiency, myocardial fibrosis, depression, age-related cognitive decline and metabolic syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.